The Department of Surgery is committed to excellence in research, in order to find new and better treatments for our patients, as part of our commitment to excellence in patient care.
We currently are performing a variety of clinical trials to evaluate the effectiveness of potentially new treatment options related to the surgical specialties represented by our physicians.
Our goal is to give patients the opportunity to participate in approved and exploratory therapies without long-distance travel.
Participation in our clinical trials is always completely voluntary and
never interferes with the normal standards for patient care.
Our clinical trials enable us to use, in addition to established therapies, the newest and most advanced technologies and treatments — long before they are available to other physicians.
Patients participate in our clinical trials only after they receive a complete explanation of their options from their surgeon and surgical team.
- Abdominal aortic aneurysm. Studying a new endovascular aortic securement system to improve AAA repair grafts (more); contact 631-444-8156.
- Abdominal aortic aneurysm. Studying a new endovascular stent graft to repair AAAs below the kidneys (more); contact 631-444-8156.
- Abdominal aortic aneurysm. Studying women who are underrepresented candidates for AAA repair (more); contact 631-444-8156.
- Abdominal aortic, aorto-iliac, and iliac aneurysms. Studying the safety and effectiveness of a stent graft used along with an iliac leg graft to surgically treat abdominal aortic, aorto-iliac, and iliac aneurysms (more); contact 631-444-8156.
- Aortic stenosis. Studying the safety and feasibility of transcatheter aortic valve replacement (TAVR) in elderly patients with severe, symptomatic aortic stenosis who are low‐risk for surgical valve replacement (more); contact 631-444-8156.
- Colorectal or ileorectal anastomosis. Studying best practices for the use of sealant in patients undergoing colorectal and ileorectal stapled anastomotic procedures (more); contact 631-444-8156.
- Gallbladder surgery. Studying use of new imaging devices for identifying anatomy during laparoscopic surgery for gallbladder removal.
- Laparoscopic ventral hernia repair. This study aims to assess the effect of different levels of muscle relaxation on the success of low-pressure insufflation, surgical conditions and patient recovery following laparoscopic repair of a ventral hernia (VHR) between 2 and 10 cm in diameter (more); contact 631-638-0292.
- Lung cancer. Studying the safety and efficacy of cryoablation therapy used to treat tumors in patients with pulmonary metastatic disease (more).
- Management of postoperative nausea and emesis for patients undergoing laparoscopic sleeve gastrectomy. This study focuses on the most common bariatric procedure performed, laparoscopic sleeve gastrectomy (LSG), and aims to assess the effect of a postoperative nausea and vomiting-specific intervention (more); contact 631-638-0292.
- Peripheral artery disease. Studying the safety and effectiveness of rivaroxaban combined with aspirin in reducing the risk of major cardiovascular events (such as stroke or heart attack) after a revascularization procedure to improve blood flow in the leg (more); contact 631-444-8156.
- Pulmonary embolism. Studying a temporary or permanent placed vein filter for patients who need to prevent blood clots forming in the lungs because they can't take anticlotting "blood thinner" medicines (more); contact 631-444-8156.
- Thoracic aortic aneurysm. Studying the long-term performance of the Relay® Thoracic Stent-Graft used in patients with thoracic aortic aneurysms and penetrating atherosclerotic ulcers (more); contact 631-444-8156.
- Treatment of paraesophageal hernia. This is a randomized, single-blinded controlled trial to compare the use of synthetic versus biologic mesh in hiatal hernia repair, two currently accepted standard of care surgical modalities (more); contact 631-638-0292.
- Venous leg ulcer. Studying the effects of the ACTitouch® Adaptive Compression in healing venous leg ulcers compared to multi-layer bandaging wraps such as PROFORE and Coban™ 2 (more); contact 631-444-8156.
For more information about our current clinical trials, please email our department administrator John M. Hutter, MBA, MS, or call him at 631-638-2326.
For more information about our current cancer-related clinical trials, please email the director of cancer clinical trials Jennifer Hofecker, MSA, or call her at 631-638-0857.